Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

Prostate cancer is the most diagnosed cancer among men in the United States. While the majority of patients who undergo surgery (prostatectomy) will essentially be cured, about 30–40% men remain at risk for disease progression and recurrence. Currently, patients are deemed at risk by evaluation of c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Research Foundation 2012
Matèries:
Genetics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284255/
https://ncbi.nlm.nih.gov/pubmed/22371711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2012.00023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars